The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Subsequent treatment with APC8015F and its effect on survival in the control arm of phase III sipuleucel-t studies.
Daniel J. George
No relevant relationships to disclose
Chadi Nabhan
No relevant relationships to disclose
Leonard G. Gomella
No relevant relationships to disclose
James Boyd Whitmore
No relevant relationships to disclose
Mark Walter Frohlich
No relevant relationships to disclose